|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 121 - 150 of 257 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
|
|
European Medicines Agency's website: BiResp Spiromax - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Biseltoc 2,13 mg-ml oraaliliuos SPC 2023-07-15
|
PL
|
Resepti/itsehoito
|
Bisolaclar 600 mg poretabletti SPC 2023-07-15
|
PL
|
Itsehoito
|
Bisolvon 0,8 mg-ml oraaliliuos SPC 2023-07-15
|
PL
|
Itsehoito
|
Bisolvon 8 mg liukeneva tabletti SPC 2023-07-15
|
PL
|
Itsehoito
|
Bisolvon 8 mg oraaliliuos, annospussi SPC 2016-10-26
|
PL
|
Itsehoito
|
Bisolvon 8 mg tabletti SPC 2023-07-15
|
PL
|
Itsehoito
|
Bisolvon Strong 1.6 mg-ml oraaliliuos SPC 2024-04-26
|
PL
|
Resepti
|
Bisoproact 2.5 mg, 5 mg, 10 mg tabletti SPC 2021-06-04
|
PL
|
Resepti
|
Bisoprolol Accord 2.5 mg, 5 mg, 10 mg tabletti, kalvopäällysteinen SPC 2023-10-18
|
PL
|
Resepti
|
Bisoprolol comp ratiopharm 5 mg-12.5 mg, 10 mg-25 mg tabletti, kalvopäällysteinen SPC 2021-12-02
|
PL
|
Resepti
|
Bisoprolol Krka 2.5 mg, 5 mg, 10 mg tabletti, kalvopäällysteinen SPC 2022-06-14
|
PL
|
Resepti
|
Bisoprolol Orion 2.5 mg, 5 mg, 10 mg tabletti SPC 2023-03-21
|
PL
|
Resepti
|
Bisoprolol ratiopharm 2.5 mg tabletti SPC 2022-08-05
|
PL
|
Resepti
|
Bisoprolol ratiopharm 5 mg, 10 mg tabletti SPC 2019-11-27
|
PL
|
Resepti
|
Bisoprolol Sandoz 2.5 mg tabletti, kalvopäällysteinen SPC 2021-06-25
|
PL
|
Resepti
|
Bisoprolol Sandoz 5 mg, 10 mg tabletti, kalvopäällysteinen SPC 2021-06-25
|
PL
|
Resepti
|
Bisoprolol Vitabalans 5 mg, 10 mg tabletti SPC 2022-05-05
|
PL
|
Resepti
|
Bitifrin 0,3 mg-ml + 5 mg-ml silmätipat, liuos SPC 2024-03-11
|
PL
|
Resepti
|
Bivalirudin Reig Jofre 250 mg kuiva-aine välikonsentraatiksi injektio-infuusionestettä varten, liuos SPC 2022-09-12
|
PL
|
Resepti
|
Bleomycin Accord 15000 IU injektio-infuusiokuiva-aine, liuosta varten SPC 2023-03-21
|
PL
|
Resepti
|
Bleomycin Baxter injektio-infuusiokuiva-aine, liuosta varten SPC 2024-07-23
|
|
|
European Medicines Agency's website: Blincyto - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Blissel 50 mikrog-g emätingeeli SPC 2024-01-25
|
|
|
European Medicines Agency's website: Blitzima - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Blitzima - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Bloctil 100 mg kapseli, kova SPC 2024-03-13
|
PL
|
Resepti
|
Bocouture 50, 100 yksikköä injektiokuiva-aine, liuosta varten SPC 2019-11-22
|
|
|
European Medicines Agency's website: Bondronat - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Bonjesta 20 mg - 20 mg säädellysti vapauttava tabletti SPC 2023-03-03
|
|
| |